[{"Assets_0_Q2_USD":163168000.0,"CommonStockSharesOutstanding_0_Q2_shares":28555379.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-10766000.0,"NetIncomeLoss_1_Q2_USD":-7228000.0,"NetIncomeLoss_2_Q2_USD":-12590000.0,"StockholdersEquity_0_Q2_USD":158389000.0,"Ticker":"AKRO","CIK":"1744659","name":"AKERO THERAPEUTICS, INC.","OfficialName":"Akero Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"399847718.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190812"}]